10.1007/s00424-017-2026-7 128
Overall, this study hints at the possibility of considering anti-diabetic drugs with weight loss-inducing effects, especially GLP-1 receptor agonists, for potential repurposing opportunities in MS, the researchers wrote.
Plainsboro, NJ: Novo Nordisk, Inc.;2019
Considering the widespread expression of GLP-1 receptors in the brain, the authors recommend that future studies should focus on identifying the key neurocircuits involved in mediating the effects of GLP-1 receptor agonists on substance use disorder, as well as determine the specific patient subtypes who are most likely to benefit from these treatments
Superior Detoxification The primary function of glutathione is to detoxify the body
Beyond Weight Loss: Added Benefits Could Guide the Choice of Anti-Obesity Medications